2m 2m 2m 2m 2m 2m 2m
TRAVERE THERAPET (TVTX)
NASDAQ
$56.92+$0.07 (+0.12%)
Price as of Oct 02, 2026 5:38 PM EDT- $5.4BMarket Cap
- 134.72%1-Year Change
- BiotechnologyIndustry
TRAVERE THERAPET (TVTX)
$56.92+$0.07 (+0.12%)
TVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $56.85 | ||
Change | -$2.03 (-3.45%) | ||
Open | $58.64 | ||
High | $59.58 | ||
Low | $56.23 | ||
Previous Close | $58.88 | ||
Volume | 2,394,617 | ||
30-Day Average Volume | 1,574,170 | ||
1-Week Change | -6.22% | ||
1-Month Change | -13.48% | ||
1-Year Change | 134.72% | ||
3-Year Change | 535.91% | ||
5-Year Change | 127.22% | ||
Fundamentals | |||
Shares Outstanding | 94.3M | ||
Total Assets | $799.4M | ||
Market Cap | $5.4B | ||
Enterprise Value | $5.8B | ||
Period: QTR TTM FY | |||
Revenue | $161.4M | ||
Net Income | -$34.8M | ||
Free Cash Flow | $58.1M | ||
EBIT | -$33.0M | ||
EBITDA | -$28.8M | ||
Net Working Capital | $463.1M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -203 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 219 | ||
P/E | -154 | ||
PEG | -20 | ||
Price/Free Cash Flow | 92 | ||
Price/Operating Cash Flow | 92 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue